News
AI for more precise radiation therapy
Learn how artificial intelligence is changing radiation therapy.
Gilead joins Oslo Cancer Cluster
Gilead is a biopharmaceutical company advancing innovative medicines
Polygenic risk scores: a European cancer priority
Polygenic risk scores can improve prevention and early detection of cancer.
New targeted therapy against osteosarcoma
Research group in Oslo Cancer Cluster Incubator develops new cancer treatment
Oncology innovators presented in Boston
Three Nordic start-ups pitched at the International Cancer Cluster Showcase 2023. This year’s International Cancer Cluster Showcase (ICCS) featured 20 emerging oncology companies that presented their recent innovations, partnering and investment opportunities on 5 June 2023 in Boston, as a satellite event to BIO International Convention. The companies were selected by innovation hubs in the […]
Cancer start-ups met investors
Investors wanted to learn about Norwegian cancer companies.
Forenkler testing av helseteknologi sammen
NorTrials Medisinsk utstyr har inngått en samarbeidsavtale med HealthCatalyst AS.
Oslo Cancer Cluster strengthens the board
Patient and industry perspectives are key as new board members join Oslo Cancer Cluster.
Exploring lung cancer: screening and early detection
Could a screening programme reduce lung cancer mortality in Norway?
Guidance on polygenic risk scores
Antegenes supports the recent guidance from the AMCG.
Suggested a Nordic Health Data Space
How can the Nordics use health data to accelerate the development of cancer precision medicine?
Europe united against cancer
The European Union has awarded 6 million euros to the ECHoS project.
